{"id":"https://openalex.org/W2593961510","doi":"https://doi.org/10.1158/2326-6074.tumimm16-b04","title":"Abstract B04: Intralesional vaccination with Ad-MAVS alters the immunosuppressive tumor microenvironment and elicits robust anti-tumor immunity in non-immunogenic cancers","display_name":"Abstract B04: Intralesional vaccination with Ad-MAVS alters the immunosuppressive tumor microenvironment and elicits robust anti-tumor immunity in non-immunogenic cancers","publication_year":2017,"publication_date":"2017-02-28","ids":{"openalex":"https://openalex.org/W2593961510","doi":"https://doi.org/10.1158/2326-6074.tumimm16-b04","mag":"2593961510"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm16-b04","doi":"https://doi.org/10.1158/2326-6074.tumimm16-b04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm16-b04","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113752760","display_name":"Gabriel De Leon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel De Leon","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100453525","display_name":"Tao Wang","orcid":"https://orcid.org/0000-0002-4355-149X","observed_orcids":["https://orcid.org/0000-0002-4355-149X"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Wang","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101624959","display_name":"Pankaj Agarwal","orcid":"https://orcid.org/0000-0002-0698-8043","observed_orcids":["https://orcid.org/0000-0002-0698-8043"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pankaj Agarwal","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012804507","display_name":"Herbert Kim Lyerly","orcid":"https://orcid.org/0000-0002-0063-4770","observed_orcids":["https://orcid.org/0000-0002-0063-4770"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Kim Lyerly","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053154937","display_name":"Zachary C. Hartman","orcid":"https://orcid.org/0000-0001-6549-8207","observed_orcids":["https://orcid.org/0000-0001-6549-8207"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Hartman","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I170897317"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"3_Supplement","first_page":"B04","last_page":"B04"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.07530000060796738,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.7490000128746033},{"id":"https://openalex.org/keywords/mavs","display_name":"MAVS","score":0.9539999961853027},{"id":"https://openalex.org/keywords/mitochondrial-antiviral-signaling-protein","display_name":"mitochondrial antiviral signaling protein","score":0.8450000286102295},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.8709999918937683},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8569999933242798},{"id":"https://openalex.org/keywords/rig-i-like-receptors","display_name":"RIG-I-like receptors","score":0.6930000185966492},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.7369999885559082},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8360000252723694},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.414000004529953},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.5019999742507935},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.5289999842643738},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":1.0},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7996347546577454},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.600626528263092},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5910288691520691},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.575387179851532},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4924493730068207},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47905004024505615},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.47633153200149536},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4576001465320587},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.45754122734069824},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.45265644788742065},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.43328818678855896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3332917094230652}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm16-b04","doi":"https://doi.org/10.1158/2326-6074.tumimm16-b04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm16-b04","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3178102646","https://openalex.org/W4282916877","https://openalex.org/W3013624323","https://openalex.org/W4220958190","https://openalex.org/W2914883607","https://openalex.org/W7140411794","https://openalex.org/W4389232903","https://openalex.org/W4207033496","https://openalex.org/W3200283887","https://openalex.org/W4408444570"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,44,101,134,164,189,206,217,229,244,253,264,278,293,346,373,404,430,451,485,515,548,567],"Hypothesis:":[3],"While":[4],"the":[5,58,78,85,94,114,125,144,155,226,394,411,423,478,517,544,560],"use":[6],"of":[7,69,77,87,96,111,162,219,233,239,261,276,281,305,319,342,356,367,376,396,400,419,426,432,446,475,500,506,520,559],"immune":[8,74,137,198,231,285,301,344,522],"checkpoint":[9,523],"blockade":[10],"has":[11],"gained":[12],"significant":[13,398],"traction":[14],"as":[15,91,93,175,177,288,443],"a":[16,36,97,160,194,241,282,363,397,497],"viable":[17],"therapy":[18],"for":[19],"certain":[20],"cancers,":[21],"many":[22],"tumors":[23,489],"remain":[24],"refractory":[25],"to":[26,30,39,47,56,128,142,382,465,481,490,510],"these":[27,48,469],"immunotherapies":[28],"due":[29],"their":[31,308,325],"highly":[32],"immunosuppressive":[33,545],"microenvironment.":[34,413],"As":[35,493],"novel":[37,498],"approach":[38,499],"boost":[40],"local":[41],"anti-tumor":[42,136,227,379,452,483,502,513,551],"immunity":[43,381,453,484,503,552],"sensitize":[45],"cancers":[46],"therapies,":[49],"we":[50,158,224,314,360],"constructed":[51],"an":[52],"adenoviral":[53,109],"(Ad)":[54],"vector":[55],"overexpress":[57],"innate":[59,73,343,507],"signaling":[60,75,89,121],"adaptor":[61,508],"molecule,":[62],"Mitochondrial":[63],"Antiviral":[64],"Signaling":[65],"protein":[66],"(MAVS).":[67],"Overexpression":[68],"MAVS":[70,112,147,271,390,420],"results":[71,421],"in":[72,84,248,327,353,406,422,441,454,553],"downstream":[76],"RIG-I":[79],"like":[80],"receptors":[81],"(RLRs)":[82],"resulting":[83],"activation":[86,505],"multiple":[88,354,407,455],"pathways":[90],"well":[92,176],"release":[95],"Th1":[98,449],"cytokine":[99],"milieu":[100],"type":[102,283,348],"I":[103,284,349],"interferons.":[104],"We":[105,414],"therefore":[106],"hypothesized":[107],"that":[108,270,316,362,389,417,472],"delivery":[110],"into":[113],"tumor":[115,126,132,156,181,211,266,320,357,412,427,433,456,479,546],"microenvironment":[116,127,157,480,547],"would":[117,123,148],"produce":[118],"robust":[119,340,550],"inflammatory":[120,350],"which":[122,458],"alter":[124],"both":[129],"efficiently":[130],"suppress":[131],"growth":[133,212,429],"stimulate":[135,482],"responses.":[138],"Methods:":[139],"In":[140,258,333],"order":[141],"determine":[143],"possible":[145],"effect":[146,228],"have":[149],"on":[150,210,564],"different":[151,179],"cell":[152,182,267,321,408,428],"types":[153,167,355,409],"within":[154,410],"infected":[159],"range":[161],"primary":[163,173],"cancer":[165],"cells":[166,171],"(Bone-marrow":[168],"derived":[169],"dendritic":[170],"(BMDCs),":[172],"fibroblasts,":[174],"5":[178],"murine":[180,265],"lines":[183,268,322],"representing":[184],"breast-4T1,":[185],"colon-CT26CL25,":[186],"bladder-MB49,":[187],"melanoma-B16F10,":[188],"prostate-TRAMPC2)":[190],"with":[191,236,336,460,541],"Ad-MAVS":[192,317,337,368,447,476,495,542],"or":[193],"control":[195,242],"Ad.":[196],"Innate":[197],"responses":[199,232,298,345,464,514],"were":[200,438],"measured":[201,225],"via":[202,330,504],"luminex":[203],"ELISA,":[204],"microarray,":[205],"RT-qPCR.":[207],"The":[208],"impact":[209],"was":[213,374],"assessed":[214],"by":[215,221,310],"MTT":[216],"expression":[218,272,304,391],"PD-L1":[220,245,311,434,491,521],"FACS.":[222],"Lastly,":[223],"adaptive":[230,380],"animals":[234],"treated":[235],"various":[237,251],"combinations":[238],"Ad-MAVS,":[240],"Ad,":[243],"targeting":[246,309],"antibodies":[247],"vivo":[249],"utilizing":[250],"immunocompetent":[252],"immune-compromised":[254],"mouse":[255],"models.":[256],"Results:":[257],"vitro":[259],"infection":[260,318],"BMDCs,":[262],"MEFs,":[263],"demonstrated":[269],"elicited":[273,339,448],"widespread":[274],"production":[275,395],"cytokines":[277,450],"chemokines":[279],"indicative":[280],"response":[286],"(such":[287],"IL-12,":[289],"TNF-alpha,":[290],"RANTES,":[291],"etc.)":[292],"interferon":[294,331],"beta.":[295],"These":[296,436],"profound":[297],"also":[299,338,415,439],"triggered":[300],"regulatory":[302],"feedback":[303],"PD-L1,":[306],"enabling":[307],"antibodies.":[312],"Additionally,":[313],"found":[315,361],"significantly":[323,369],"inhibited":[324],"proliferation":[326],"vitro,":[328],"likely":[329],"pathways.":[332],"vivo,":[334,442],"treatment":[335,366],"stimulation":[341,431],"numerous":[347],"cytokines.":[351],"Moreover,":[352],"bearing":[358],"animals,":[359],"single":[364],"intralesional":[365,444],"prolonged":[370],"overall":[371],"survival":[372],"capable":[375],"eliciting":[377],"systemic":[378,462],"non-immunogenic":[383,488,554],"tumors.":[384],"Conclusion:":[385],"Our":[386],"study":[387],"identifies":[388],"can":[392],"elicit":[393],"number":[399],"Th1-type":[401],"cytokines,":[402],"chemokines,":[403],"interferon-beta":[405],"demonstrate":[416,471],"overexpression":[418],"direct":[424],"suppression":[425],"expression.":[435],"activities":[437],"observed":[440],"injection":[445,474],"types,":[457],"correlated":[459],"enhanced":[461],"T-cell":[463],"tumor-specific":[466],"epitopes.":[467],"Collectively,":[468],"data":[470],"intralesion":[473],"alters":[477,543],"potentially":[486,516],"sensitizes":[487],"therapies.":[492],"such,":[494],"represents":[496],"stimulating":[501],"molecules":[509],"improve":[511],"immunogenic":[512],"therapeutic":[518],"efficacy":[519],"blockade.":[524],"Citation":[525],"Format:":[526],"Gabriel":[527],"De":[528],"Leon,":[529],"Tao":[530],"Wang,":[531],"Pankaj":[532],"Agarwal,":[533],"H.":[534],"Kim":[535],"Lyerly,":[536],"Zachary":[537],"Hartman.":[538],"Intralesional":[539],"vaccination":[540],"elicits":[549],"cancers.":[555],"[abstract].":[556],"In:":[557],"Proceedings":[558],"AACR":[561],"Special":[562],"Conference":[563],"Tumor":[565],"Immunology":[566],"Immunotherapy;":[568],"2016":[569],"Oct":[570],"20-23;":[571],"Boston,":[572],"MA.":[573],"Philadelphia":[574],"(PA):":[575],"AACR;":[576],"Cancer":[577],"Immunol":[578],"Res":[579],"2017;5(3":[580],"Suppl):Abstract":[581],"nr":[582],"B04.":[583]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-16T00:00:00"}